OVERVIEW

Advances in Inflammatory Bowel Diseases 2018 - Pediatric Track is organized by Healthcare Made Practical (HMP) Communications LLC and will be held from Dec 21, 2018 - Dec 21, 2019.

CME
Physicians
Imedex designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 3.50 AAPA Category 1 credits.
PAs should only claim credit commensurate with the extent of their participation.

CNE
This continuing nursing education activity awards 3.50 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 3.50 contact hours.

CPE
This knowledge-based activity (JA0006201-9999-18-247-H01-P) is approved for 3.50 contact hours (0.03 CEUs) of continuing pharmacy education.

Target Audience:
This educational activity is designed for gastroenterologists and other healthcare professionals (physicians-in-training, nurses, pharmacists, physician assistants, etc) involved and/or interested in the therapeutic management of patients with IBD.

Overview:
The therapeutic landscape of IBD has evolved significantly over recent years, and new medication approvals, biosimilar approvals, and other potential targeted therapies for IBD are emerging at a rapid pace. These novel therapies have led to significant improvements in the clinical management of IBD and have led to recommendations for earlier diagnosis, personalized treatment, and treating to target. With these rapid advances, pediatricians are challenged to critically assess emerging data and to implement safe and effective solutions for current clinical challenges. Pediatricians need expert guidance to help them integrate new and promising data into their gastroenterology practices.

Designed to meet the educational needs of the entire IBD healthcare team, the 2018 Advances in Inflammatory Bowel Diseases (AIBD) meeting provided pediatricians with expert guidance on the latest advances and new insights for the personalized care of patients with IBD. This webcast highlights the clinically significant information presented during the 2018 AIBD ‘Pediatric Track’ in Orlando, Florida on December 14-15, 2018.

Objectives:
Upon successful completion of this educational activity, participants should be better able to:
• Discuss the benefits and side effects of IBD medications indicated for pediatric patients